Fierce Pharma

JUNE 17, 2024

Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. |

Sales 116

Sales Marketing Trials Drugs 116

Pharma Mirror

APRIL 14, 2021

The role of pharma sales reps is an incredibly important part of this lifecycle from initial research to point of sale and distribution, with reps connecting the groundbreaking research and technology of pharma companies with healthcare professionals and medical establishments.

Sales 130

Sales Marketing Pharma Companies Production 130

Pharma Mirror

JUNE 23, 2023

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).

Sales 130

Sales Development Marketing 130

Bio Pharma Dive

AUGUST 23, 2022

The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales.

Sales 273

Sales Medicine Drugs Marketing 273

Bio Pharma Dive

APRIL 18, 2023

Revenue topped analyst forecasts on strong market performance from the pharma’s multiple myeloma treatments, as well as the last quarter of significant COVID-19 vaccine sales.

Sales 213

Sales Vaccination Vaccine Drugs 213

Bio Pharma Dive

APRIL 2, 2024

Stalking horse bidder Merz Therapeutics could get rights to Acorda’s three marketed drugs if its $185 million proposal holds.

Sales 287

Sales Marketing Drugs 287

BioSpace

APRIL 16, 2024

On the heels of a Phase IIb win, Arrowhead Pharmaceuticals’ plozasiran could fulfill a critical unmet need in dyslipidemia treatment bringing in $707 million in sales by 2032, according to data analytics firm GlobalData.

Sales 103

Sales Marketing 103

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Sales 98

Sales Marketing Branding Production 98

pharmaphorum

MAY 8, 2024

The first commercial sales of Spectral AI's DeepView wound imaging system for burns are due to start in the UK, its first market, later this year

Sales 112

Sales Marketing 112

Bio Pharma Dive

JANUARY 31, 2023

The company expects yearly revenue from Comirnaty and Paxlovid to fall by nearly two thirds in 2023 amid lower vaccination rates and a shift to private market sales.

Sales 156

Sales Vaccination Vaccine Drugs 156

Pharmaceutical Technology

APRIL 28, 2023

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Sales 130

Sales Insulin Marketing FDA Approval 130

Bio Pharma Dive

OCTOBER 25, 2022

Treatment is now mostly of infants newly diagnosed with spinal muscular atrophy, as many of those previously eligible either already received Zolgensma or other drugs from Biogen and Roche.

Gene Therapy 280

Gene Therapy Sales Gene Marketing 280

Fierce Pharma

APRIL 5, 2024

Despite Boehringer Ingelheim’s 2021 Humira biosimilar approval being heralded by some analysts as a “landmark achievement” for the field, the drug—dubbed Cyltezo—has struggled to gain traction than | Facing lackluster Cyltezo sales, Boehringer Ingelheim will prune its ranks in the U.S.

Sales 101

Sales Marketing Drugs 101

Pharma Marketing Network

APRIL 21, 2021

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences.

Sales 90

Sales Marketing Life Science Compliance 90

Pharmaceutical Technology

JANUARY 25, 2023

It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.

Sales 147

Sales Vaccination Vaccine Marketing 147

Pharmaceutical Technology

MARCH 30, 2023

The breakthrough drug is predicted to be a blockbuster, generating total forecast sales of $12.9bn between 2023 and 2028. Leqembi is forecast to generate total sales of $12.9bn worldwide between 2023 and 2028. This would make Leqembi’s forecast sales 17 times greater than those of Aricept.

Sales 147

Sales Drugs Antibody FDA Approval 147

pharmaphorum

DECEMBER 23, 2022

Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes.

Sales 92

Sales Marketing Life Science Compliance 92

Fierce Pharma

JANUARY 13, 2023

AstraZeneca pulls leukemia drug Lumoxiti off market after disappointing sales. Fri, 01/13/2023 - 09:29.

Sales 101

Sales Marketing Drugs 101

Fierce Pharma

MAY 6, 2024

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the next leg of its commercial journey. With plans to have at least 10 potentially registrational trials underway by the end of 2024, BioNTech is plotting the first wave of its market debut in oncology from 2026 onward.

Sales 128

Sales Vaccination Vaccine Trials 128

Pharmaceutical Technology

MARCH 30, 2023

The breakthrough drug is predicted to be a blockbuster, generating total forecast sales of $12.9bn between 2023 and 2028. Leqembi is forecast to generate total sales of $12.9bn worldwide between 2023 and 2028. This would make Leqembi’s forecast sales 17 times greater than those of Aricept.

Sales 130

Sales Drugs Antibody FDA Approval 130

BioSpace

MAY 14, 2024

Crackdowns on drug pricing have forced one major insulin out of the market. Are more to come?

Insulin 110

Insulin Marketing Sales Drugs 110

BioSpace

APRIL 25, 2024

Humira maintained its blockbuster status and market share dominance in the first quarter of 2024, but experienced a drop in sales as biosimilar competition heated up, AbbVie reported on Friday.

Sales 97

Sales Marketing 97

Bio Pharma Dive

MAY 5, 2022

The biotech reported positive results from a study meant to expand Vyvgart's use to another immune disorder, while sales from the drug's first quarter on the market exceeded expectations.

Sales 130

Sales Drugs Trials Marketing 130

Bio Pharma Dive

MARCH 13, 2023

In its first full quarter on the market, Amylyx’s Relyvrio generated revenue just shy of $22 million, or roughly five times what some analysts were forecasting a month ago.

Sales 238

Sales Drugs Marketing 238

BioSpace

JUNE 7, 2022

Sales and marketing roles in the life sciences field are in high demand. To help with your job search, we've compiled a guide to sales and marketing jobs in the life sciences industry.

Life Science 78

Life Science Sales Marketing 78

World of DTC Marketing

APRIL 6, 2022

DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Paid Media – The most commonly used KPI in marketing is essentially worthless.

Marketing 196

Marketing Sales Pharma Companies Doctors 196

Fierce Pharma

APRIL 23, 2024

The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales.

Marketing 110

Marketing Sales Drugs 110

Pharmaceutical Technology

FEBRUARY 8, 2023

The top 20 companies in the global biopharma industry saw 5.4%* aggregate market capitalization from $3.43 Pfizer maintained its third-place position in the market in 2022, reporting a market capitalization of $287.6 witnessed the biggest market capitalization growth of 45.3% trillion to $3.61 billion on Dec 31, 2022.

Marketing 195

Marketing Sales Vaccination Vaccine 195

World of DTC Marketing

NOVEMBER 16, 2021

SUMMARY: Omnichannel marketing employs the simultaneous implementation of channels across personal, non-personal, and media and addresses the integrated needs of multiple stakeholders – consumers/patients, healthcare professionals, and payers. Today there are microsegments of markets, and one message shouldn’t be used for all.

Marketing 253

Marketing Doctors Doctor Sales 253

Bio Pharma Dive

MARCH 15, 2022

Instead of sharing global profits and losses, Eisai will receive royalties tied to net sales of the Alzheimer's drug. Biogen, meanwhile, said the amended deal should make it easier to "address market developments."

Sales 148

Sales Marketing Development Drugs 148

Fierce Pharma

MAY 1, 2024

Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen.

Sales 117

Sales Marketing Medicine Production 117

Pharmaceutical Technology

DECEMBER 15, 2022

In an expanded version of the sales forecast from GlobalData’s June 2022 publication, Cardiomyopathies: Global Drug Forecast and Market Analysis , the global cardiomyopathies market is expected to grow from $3.07bn last year to $9.63bn in 2031. of sales in 2021 and 2031 respectively.

Marketing 130

Marketing Sales Clinical Trials Clinical Trials 130

Intouch Solutions

MAY 26, 2023

Even as some of the effects of COVID-19 have begun to wane, it’s a challenging time to be a life-sciences sales representative. Technology was supposed to bring on a new future for the sales interaction: greater insight into the customer, leading to better and more effective interactions. How can we do better?

Sales 98

Sales Life Science Marketing Production 98

World of DTC Marketing

JANUARY 14, 2021

SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. To master digital marketing, pharma needs to be prepared to fail. Will digital replace the sales force?

Marketing 180

Marketing Pharma Companies Sales Doctors 180

Bio Pharma Dive

OCTOBER 31, 2023

The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales.

Vaccination 171

Vaccination Vaccine Sales Marketing 171

World of DTC Marketing

MARCH 9, 2021

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.

Marketing 289

Marketing Branding Packaging Packaging 289

Fierce Pharma

JANUARY 3, 2024

Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales. Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales.

Sales 115

Sales Drugs Marketing 115